"10.1371_journal.pone.0018170","plos one","2011-03-23T00:00:00Z","Sara Landgren; Jeffrey A Simms; Dag S Thelle; Elisabeth Strandhagen; Selena E Bartlett; Jörgen A Engel; Elisabet Jerlhag","Department of Pharmacology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, California, United States of America; Department of Biostatistics, Institute of Basic Medical Science, University of Oslo, Oslo, Norway; School of Public Health and Community Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden","Conceived and designed the experiments: SL JAE EJ. Performed the experiments: SL JAS EJ. Analyzed the data: SL JAS EJ. Contributed reagents/materials/analysis tools: SL JAS DST ES SEB JAE EJ. Wrote the paper: SL JAS DST ES SEB JAE EJ.","Authors Elisabet Jerlhag and Jörgen A. Engel are owners in a company holding a patent regarding treatment of chemical addiction by administering a compound which blocks ghrelin action. This does not alter the authors adherence to the PLoS ONE policies on sharing data and materials.","2011","03","Sara Landgren","SL",7,TRUE,3,3,3,7,TRUE,TRUE,FALSE,0,NA,FALSE
